Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data.
A single mutation can alter cellular and global homeostatic mechanisms and give rise to multiple clinical diseases. We hypothesized that these disease mechanisms could be identified using low minor allele frequency (MAF<0.1) non-synonymous SNPs (nsSNPs) associated with "mechanistic phenotype...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3861317?pdf=render |
id |
doaj-0f6b6da6da1d4ddf9b51b5dedbf40ee6 |
---|---|
record_format |
Article |
spelling |
doaj-0f6b6da6da1d4ddf9b51b5dedbf40ee62020-11-25T02:32:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8150310.1371/journal.pone.0081503Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data.Jonathan D MosleySara L Van DriestEmma K LarkinPeter E WeekeJohn S WitteQuinn S WellsJason H KarnesYan GuoLisa BastaracheLana M OlsonCatherine A McCartyJennifer A PachecoGail P JarvikDavid S CarrellEric B LarsonDavid R CrosslinIftikhar J KulloGerard TrompHelena KuivaniemiDavid J CareyMarylyn D RitchieJosh C DennyDan M RodenA single mutation can alter cellular and global homeostatic mechanisms and give rise to multiple clinical diseases. We hypothesized that these disease mechanisms could be identified using low minor allele frequency (MAF<0.1) non-synonymous SNPs (nsSNPs) associated with "mechanistic phenotypes", comprised of collections of related diagnoses. We studied two mechanistic phenotypes: (1) thrombosis, evaluated in a population of 1,655 African Americans; and (2) four groupings of cancer diagnoses, evaluated in 3,009 white European Americans. We tested associations between nsSNPs represented on GWAS platforms and mechanistic phenotypes ascertained from electronic medical records (EMRs), and sought enrichment in functional ontologies across the top-ranked associations. We used a two-step analytic approach whereby nsSNPs were first sorted by the strength of their association with a phenotype. We tested associations using two reverse genetic models and standard additive and recessive models. In the second step, we employed a hypothesis-free ontological enrichment analysis using the sorted nsSNPs to identify functional mechanisms underlying the diagnoses comprising the mechanistic phenotypes. The thrombosis phenotype was solely associated with ontologies related to blood coagulation (Fisher's p = 0.0001, FDR p = 0.03), driven by the F5, P2RY12 and F2RL2 genes. For the cancer phenotypes, the reverse genetics models were enriched in DNA repair functions (p = 2×10-5, FDR p = 0.03) (POLG/FANCI, SLX4/FANCP, XRCC1, BRCA1, FANCA, CHD1L) while the additive model showed enrichment related to chromatid segregation (p = 4×10-6, FDR p = 0.005) (KIF25, PINX1). We were able to replicate nsSNP associations for POLG/FANCI, BRCA1, FANCA and CHD1L in independent data sets. Mechanism-oriented phenotyping using collections of EMR-derived diagnoses can elucidate fundamental disease mechanisms.http://europepmc.org/articles/PMC3861317?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jonathan D Mosley Sara L Van Driest Emma K Larkin Peter E Weeke John S Witte Quinn S Wells Jason H Karnes Yan Guo Lisa Bastarache Lana M Olson Catherine A McCarty Jennifer A Pacheco Gail P Jarvik David S Carrell Eric B Larson David R Crosslin Iftikhar J Kullo Gerard Tromp Helena Kuivaniemi David J Carey Marylyn D Ritchie Josh C Denny Dan M Roden |
spellingShingle |
Jonathan D Mosley Sara L Van Driest Emma K Larkin Peter E Weeke John S Witte Quinn S Wells Jason H Karnes Yan Guo Lisa Bastarache Lana M Olson Catherine A McCarty Jennifer A Pacheco Gail P Jarvik David S Carrell Eric B Larson David R Crosslin Iftikhar J Kullo Gerard Tromp Helena Kuivaniemi David J Carey Marylyn D Ritchie Josh C Denny Dan M Roden Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. PLoS ONE |
author_facet |
Jonathan D Mosley Sara L Van Driest Emma K Larkin Peter E Weeke John S Witte Quinn S Wells Jason H Karnes Yan Guo Lisa Bastarache Lana M Olson Catherine A McCarty Jennifer A Pacheco Gail P Jarvik David S Carrell Eric B Larson David R Crosslin Iftikhar J Kullo Gerard Tromp Helena Kuivaniemi David J Carey Marylyn D Ritchie Josh C Denny Dan M Roden |
author_sort |
Jonathan D Mosley |
title |
Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. |
title_short |
Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. |
title_full |
Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. |
title_fullStr |
Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. |
title_full_unstemmed |
Mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using GWAS data. |
title_sort |
mechanistic phenotypes: an aggregative phenotyping strategy to identify disease mechanisms using gwas data. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
A single mutation can alter cellular and global homeostatic mechanisms and give rise to multiple clinical diseases. We hypothesized that these disease mechanisms could be identified using low minor allele frequency (MAF<0.1) non-synonymous SNPs (nsSNPs) associated with "mechanistic phenotypes", comprised of collections of related diagnoses. We studied two mechanistic phenotypes: (1) thrombosis, evaluated in a population of 1,655 African Americans; and (2) four groupings of cancer diagnoses, evaluated in 3,009 white European Americans. We tested associations between nsSNPs represented on GWAS platforms and mechanistic phenotypes ascertained from electronic medical records (EMRs), and sought enrichment in functional ontologies across the top-ranked associations. We used a two-step analytic approach whereby nsSNPs were first sorted by the strength of their association with a phenotype. We tested associations using two reverse genetic models and standard additive and recessive models. In the second step, we employed a hypothesis-free ontological enrichment analysis using the sorted nsSNPs to identify functional mechanisms underlying the diagnoses comprising the mechanistic phenotypes. The thrombosis phenotype was solely associated with ontologies related to blood coagulation (Fisher's p = 0.0001, FDR p = 0.03), driven by the F5, P2RY12 and F2RL2 genes. For the cancer phenotypes, the reverse genetics models were enriched in DNA repair functions (p = 2×10-5, FDR p = 0.03) (POLG/FANCI, SLX4/FANCP, XRCC1, BRCA1, FANCA, CHD1L) while the additive model showed enrichment related to chromatid segregation (p = 4×10-6, FDR p = 0.005) (KIF25, PINX1). We were able to replicate nsSNP associations for POLG/FANCI, BRCA1, FANCA and CHD1L in independent data sets. Mechanism-oriented phenotyping using collections of EMR-derived diagnoses can elucidate fundamental disease mechanisms. |
url |
http://europepmc.org/articles/PMC3861317?pdf=render |
work_keys_str_mv |
AT jonathandmosley mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT saralvandriest mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT emmaklarkin mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT petereweeke mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT johnswitte mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT quinnswells mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT jasonhkarnes mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT yanguo mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT lisabastarache mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT lanamolson mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT catherineamccarty mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT jenniferapacheco mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT gailpjarvik mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT davidscarrell mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT ericblarson mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT davidrcrosslin mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT iftikharjkullo mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT gerardtromp mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT helenakuivaniemi mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT davidjcarey mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT marylyndritchie mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT joshcdenny mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata AT danmroden mechanisticphenotypesanaggregativephenotypingstrategytoidentifydiseasemechanismsusinggwasdata |
_version_ |
1724821518050918400 |